Thermo Fisher Scientific SARS-CoV-2 ORF8 Polyclonal Antibody

Applications

Tested Dilution

Publications

Western Blot (WB)

1:500-1:1,000

-

ELISA (ELISA)

1:10,000

-

Immunoprecipitation (IP)

1:50-1:250

-

Product Specifications

Species Reactivity

Virus

Host/Isotype

Rabbit / IgG

Class

Polyclonal

Type

Antibody

Immunogen

Synthetic peptide taken from unique amino acid sequence on ORF8 [Severe acute respiratory syndrome coronavirus 2].

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

0.5-1.5 mg/mL

Purification

Affinity chromatography

Storage buffer

proprietary buffer, pH 7.4-7.8, with 0.5% BSA, 30% glycerol

Contains

0.02% sodium azide

Storage conditions

-20°C

Shipping conditions

Ambient (domestic); Wet ice (international)

Target Information

The structure of the SARS-CoV-2 ORF8 protein involves two novel intermolecular interfaces layered onto an ORF7 fold. One is mediated by a disulfide bond, the other is noncovalent, and both are novel approximately 60-residue core is similar to SARS-CoV-2 ORF7a. The addition of two dimerization interfaces is unique to SARS-CoV-2 ORF8.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.